| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.34e-12 | 14 | 147 | 7 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.27e-08 | 46 | 147 | 7 | GO:0005245 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SLC9A1 SLC9A3 SLC9A5 KCNJ1 SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATP12A | 3.44e-07 | 465 | 147 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 3.45e-07 | 9 | 147 | 4 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 3.45e-07 | 9 | 147 | 4 | GO:0099626 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A NDUFB5 ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 KCNJ1 SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATP12A | 4.39e-07 | 664 | 147 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ABCC4 GJD2 NDUFB5 FABP2 ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 KCNJ1 GLRB NPC1L1 SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATG9A ATP12A SLC27A5 SLC16A10 | 7.25e-07 | 1289 | 147 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S P2RX5 KCNJ1 SCN10A CACNA1I CACNA1G | 9.98e-07 | 182 | 147 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S P2RX5 KCNJ1 SCN10A CACNA1I CACNA1G | 1.10e-06 | 184 | 147 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.17e-06 | 26 | 147 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A NDUFB5 ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATP12A | 1.53e-06 | 793 | 147 | 20 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ZACN P2RX5 KCNJ1 SCN8A SCN10A CACNA1I CACNA1G | 1.59e-06 | 343 | 147 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ABCC4 GJD2 NDUFB5 FABP2 ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATP12A SLC27A5 SLC16A10 | 1.63e-06 | 1180 | 147 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ABCC4 NDUFB5 SLC9A1 SLC9A3 SLC9A5 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATP12A | 3.12e-06 | 758 | 147 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A NDUFB5 SLC9A1 SLC9A3 SLC9A5 KCNJ1 SCN8A SCN10A CACNA1I CACNA1G NIPA1 ATP12A | 3.83e-06 | 627 | 147 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC9A1 SLC9A3 SLC9A5 SCN8A SCN10A CACNA1I CACNA1G ATP12A | 5.02e-06 | 171 | 147 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ZACN P2RX5 KCNJ1 GLRB SCN10A CACNA1I CACNA1G | 7.02e-06 | 334 | 147 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ZACN P2RX5 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G | 7.77e-06 | 459 | 147 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A GJD2 ZACN P2RX5 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G | 7.94e-06 | 525 | 147 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A GJD2 ZACN P2RX5 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G | 8.12e-06 | 526 | 147 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S KCNJ1 CACNA1I CACNA1G | 1.71e-05 | 152 | 147 | 8 | GO:0022843 |
| GeneOntologyMolecularFunction | sodium channel activity | 3.97e-05 | 52 | 147 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.80e-05 | 129 | 147 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved SA node cell action potential | 5.38e-05 | 2 | 147 | 2 | GO:0086059 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.29e-04 | 151 | 147 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.34e-04 | 14 | 147 | 3 | GO:0015386 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.61e-04 | 3 | 147 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 2.04e-04 | 16 | 147 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.10e-04 | 230 | 147 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 3.47e-04 | 19 | 147 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 5.31e-04 | 5 | 147 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 5.31e-04 | 5 | 147 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.00e-03 | 27 | 147 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DENND5B ARHGEF28 OBSCN DNM1L DENND1C TBC1D8B RUNDC3A TBC1D4 DENND5A ARHGEF37 SOS1 | 1.35e-03 | 507 | 147 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DENND5B ARHGEF28 OBSCN DNM1L DENND1C TBC1D8B RUNDC3A TBC1D4 DENND5A ARHGEF37 SOS1 | 1.35e-03 | 507 | 147 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | CDP-alcohol phosphatidyltransferase activity | 1.46e-03 | 8 | 147 | 2 | GO:0017169 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B ABCC4 MYO1E NAIP SRPRA TOR4A ATP12A DNAH6 SNRNP200 HSP90AB3P | 1.61e-03 | 441 | 147 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.64e-03 | 231 | 147 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B ABCC4 MYO1E GBP7 NAIP DNM1L SRPRA TOR4A GNAO1 GNAZ ATP12A DNAH6 SNRNP200 HSP90AB3P | 1.77e-03 | 775 | 147 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B ABCC4 MYO1E NAIP SRPRA TOR4A UBA1 ATP12A DNAH6 SNRNP200 SLC27A5 HSP90AB3P | 1.98e-03 | 614 | 147 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B ABCC4 MYO1E GBP7 NAIP DNM1L SRPRA TOR4A GNAO1 GNAZ ATP12A DNAH6 SNRNP200 HSP90AB3P | 3.64e-03 | 839 | 147 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B ABCC4 MYO1E GBP7 NAIP DNM1L SRPRA TOR4A GNAO1 GNAZ ATP12A DNAH6 SNRNP200 HSP90AB3P | 3.68e-03 | 840 | 147 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B ABCC4 MYO1E GBP7 NAIP DNM1L SRPRA TOR4A GNAO1 GNAZ ATP12A DNAH6 SNRNP200 HSP90AB3P | 3.68e-03 | 840 | 147 | 14 | GO:0016818 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 CACNA1I CACNA1G ATP12A | 1.71e-12 | 142 | 147 | 14 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 CACNA1I CACNA1G ATP12A | 1.71e-12 | 142 | 147 | 14 | GO:0098659 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S P2RX5 MS4A1 CACNA1I CACNA1G | 4.91e-11 | 48 | 147 | 9 | GO:0098703 |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S P2RX5 MS4A1 CACNA1I CACNA1G | 4.91e-11 | 48 | 147 | 9 | GO:1902656 |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 CACNA1I CACNA1G ATP12A SLC27A5 | 1.04e-10 | 230 | 147 | 15 | GO:0098739 |
| GeneOntologyBiologicalProcess | calcium ion import | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S P2RX5 MS4A1 CACNA1I CACNA1G | 3.40e-08 | 98 | 147 | 9 | GO:0070509 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.93e-07 | 36 | 147 | 6 | GO:0086010 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.40e-06 | 112 | 147 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1A CACNA1B CACNA1E AMFR SCN11A PDE1B NCAM1 DCTN1 ADCY3 SHANK3 CELSR1 GLRB SCN8A VPS13A MTNR1A AOC3 SCN10A NINJ1 GNAO1 VPS13B DGAT1 | 1.43e-06 | 891 | 147 | 21 | GO:0007610 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ABCC4 SHANK3 ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 GLRB SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 ATP12A | 4.10e-06 | 1115 | 147 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | neuronal action potential | 5.75e-06 | 63 | 147 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A DNM1L SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 GNAO1 ATP12A | 8.62e-06 | 1000 | 147 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 ATP12A | 1.23e-05 | 942 | 147 | 20 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A ABCC4 DNM1L SHANK3 ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 GLRB SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 GNAO1 ATP12A | 1.33e-05 | 1374 | 147 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A DNM1L SLC9A1 P2RX5 MS4A1 AHR CACNA1I CACNA1G GNAO1 | 1.73e-05 | 509 | 147 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN11A SLC9A1 SLC9A3 SLC9A5 SCN8A SCN10A CACNA1I CACNA1G ATP12A | 1.88e-05 | 208 | 147 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A DNM1L ZACN SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 GNAO1 ATP12A | 2.41e-05 | 1157 | 147 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SLC9A1 P2RX5 MS4A1 AHR CACNA1I CACNA1G | 2.51e-05 | 392 | 147 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.59e-05 | 121 | 147 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S P2RX5 MS4A1 CACNA1I CACNA1G | 2.63e-05 | 217 | 147 | 9 | GO:0097553 |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A SLC9A1 SLC9A3 SLC9A5 KCNJ1 SCN8A SCN10A CACNA1I CACNA1G ATP12A | 2.88e-05 | 275 | 147 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | response to pain | 3.10e-05 | 51 | 147 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 ATP12A | 3.12e-05 | 922 | 147 | 19 | GO:0098662 |
| GeneOntologyBiologicalProcess | leukocyte migration involved in inflammatory response | 3.28e-05 | 26 | 147 | 4 | GO:0002523 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.37e-05 | 126 | 147 | 7 | GO:0033555 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 GLRB SCN8A SCN10A AHR CACNA1I CACNA1G NIPA1 ATP12A | 3.68e-05 | 1017 | 147 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | locomotory behavior | CACNA1A CACNA1B CACNA1E PDE1B SHANK3 CELSR1 GLRB SCN8A VPS13A GNAO1 | 3.78e-05 | 284 | 147 | 10 | GO:0007626 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.42e-05 | 93 | 147 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | heart contraction | CACNA1B CACNA1D CACNA1E SCN11A DNM1L SLC9A1 SCN8A SCN10A CACNA1G GNAO1 | 5.67e-05 | 298 | 147 | 10 | GO:0060047 |
| GeneOntologyBiologicalProcess | blood circulation | TBXAS1 CACNA1B CACNA1D CACNA1E SCN11A DNM1L CBS SLC9A1 SCN8A AOC3 SCN10A AHR CACNA1G GNAO1 ALOX5 | 6.25e-05 | 648 | 147 | 15 | GO:0008015 |
| GeneOntologyBiologicalProcess | export from cell | CACNA1A CACNA1B CACNA1D CACNA1E SCN11A ABCC4 GALR1 AP1M2 DNM1L NCAM1 SLC9A1 VPS13A MTNR1A CACNA1I CACNA1G GNAO1 GNAZ ATP12A ALOX5 DGAT1 SLC16A10 | 7.00e-05 | 1153 | 147 | 21 | GO:0140352 |
| GeneOntologyBiologicalProcess | circulatory system process | TBXAS1 CACNA1B CACNA1D CACNA1E SCN11A ABCC4 DNM1L CBS SLC9A1 SCN8A AOC3 SCN10A AHR CACNA1G GNAO1 ALOX5 | 7.05e-05 | 733 | 147 | 16 | GO:0003013 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 7.62e-05 | 32 | 147 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | heart process | CACNA1B CACNA1D CACNA1E SCN11A DNM1L SLC9A1 SCN8A SCN10A CACNA1G GNAO1 | 7.67e-05 | 309 | 147 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 8.01e-05 | 62 | 147 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | action potential | 9.92e-05 | 201 | 147 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | TBXAS1 CACNA1B CACNA1D CACNA1E SLC9A1 SCN10A AHR CACNA1G GNAO1 ALOX5 | 1.19e-04 | 326 | 147 | 10 | GO:1903522 |
| GeneOntologyBiologicalProcess | secretion | CACNA1A CACNA1B CACNA1D CACNA1E SCN11A ABCC4 GALR1 AP1M2 DNM1L NCAM1 S100A8 CELSR2 VPS13A MTNR1A CACNA1I CACNA1G GNAO1 GNAZ ALOX5 DGAT1 SLC16A10 | 1.56e-04 | 1221 | 147 | 21 | GO:0046903 |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1A CACNA1B CACNA1D CACNA1E SCN11A ABCC4 GALR1 AP1M2 DNM1L NCAM1 VPS13A MTNR1A CACNA1I CACNA1G GNAO1 GNAZ ALOX5 DGAT1 SLC16A10 | 2.05e-04 | 1064 | 147 | 19 | GO:0032940 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.01e-04 | 127 | 147 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 3.97e-04 | 87 | 147 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | osteoclast development | 4.95e-04 | 22 | 147 | 3 | GO:0036035 | |
| GeneOntologyBiologicalProcess | bone cell development | 4.95e-04 | 22 | 147 | 3 | GO:0098751 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 4.97e-04 | 5 | 147 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | cilium movement | 5.80e-04 | 261 | 147 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | intestinal lipid absorption | 6.43e-04 | 24 | 147 | 3 | GO:0098856 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S MYO1E DNM1L DENND1C SLC9A1 SLC9A3 SLC9A5 P2RX5 MS4A1 KCNJ1 CACNA1I CACNA1G ATP12A SLC27A5 | 6.46e-04 | 1074 | 147 | 18 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1A CACNA1D SCN11A GJD2 SHANK3 SLC9A1 P2RX5 GLRB SCN8A SCN10A CACNA1I CACNA1G | 6.79e-04 | 559 | 147 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of system process | TBXAS1 CACNA1B CACNA1D CACNA1E CACNA1S GALR1 SHANK3 SLC9A1 SCN10A AHR CACNA1G GNAO1 ALOX5 DGAT1 | 7.82e-04 | 734 | 147 | 14 | GO:0044057 |
| GeneOntologyBiologicalProcess | peptide secretion | CACNA1D CACNA1E S100A8 MTNR1A GNAO1 GNAZ ALOX5 DGAT1 SLC16A10 | 8.08e-04 | 343 | 147 | 9 | GO:0002790 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.09e-04 | 153 | 147 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | signal release | CACNA1A CACNA1B CACNA1D CACNA1E ABCC4 GALR1 DNM1L MTNR1A GNAO1 GNAZ ALOX5 DGAT1 SLC16A10 | 8.18e-04 | 653 | 147 | 13 | GO:0023061 |
| GeneOntologyBiologicalProcess | central nervous system development | CACNA1A HSD17B7 ARHGEF28 NCAM1 VIT EZH2 DCTN1 CBS SHANK3 FANCC S100A8 CELSR1 CELSR2 VPS13A PLXNA4 HYDIN MYO16 VPS13B SOS1 | 8.73e-04 | 1197 | 147 | 19 | GO:0007417 |
| GeneOntologyBiologicalProcess | amide transport | CACNA1D CACNA1E ABCC4 S100A8 MTNR1A GNAO1 GNAZ ALOX5 DGAT1 SLC16A10 | 8.79e-04 | 420 | 147 | 10 | GO:0042886 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | CACNA1B CACNA1D SHANK3 SLC9A1 SLC9A3 P2RX5 MS4A1 KCNJ1 SCN10A AHR CACNA1G GNAO1 | 8.94e-04 | 577 | 147 | 12 | GO:0043269 |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 9.15e-04 | 27 | 147 | 3 | GO:0098719 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 9.51e-04 | 217 | 147 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | peptide transport | CACNA1D CACNA1E S100A8 MTNR1A GNAO1 GNAZ ALOX5 DGAT1 SLC16A10 | 1.03e-03 | 355 | 147 | 9 | GO:0015833 |
| GeneOntologyBiologicalProcess | post-embryonic hemopoiesis | 1.03e-03 | 7 | 147 | 2 | GO:0035166 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.28e-08 | 46 | 148 | 7 | GO:0005891 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.60e-08 | 17 | 148 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | calcium channel complex | 8.53e-07 | 73 | 148 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A NDUFB5 ZACN SLC9A1 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G ATP12A | 9.82e-07 | 523 | 148 | 16 | GO:1902495 |
| GeneOntologyCellularComponent | sodium channel complex | 1.72e-06 | 29 | 148 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A NDUFB5 ZACN SLC9A1 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G ATP12A | 1.89e-06 | 550 | 148 | 16 | GO:1990351 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S AMFR SCN11A GJD2 COPB1 RPN2 AP1M2 SRPRA VPS26A DCTN1 NDUFB5 ZACN SLC9A1 KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G GNAO1 DENND5A GNAZ ATP12A | 6.00e-06 | 1498 | 148 | 27 | GO:0098796 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SCN8A SCN10A CACNA1I CACNA1G | 7.00e-06 | 235 | 148 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A KCNJ1 GLRB SCN8A SCN10A CACNA1I CACNA1G | 1.65e-05 | 378 | 148 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S AMFR SCN11A PDE1B NAIP NCAM1 DCTN1 SHANK3 SLC9A5 GLRB SCN8A VPS13A MTNR1A CACNA1G GNAO1 GNAZ ALOX5 SOS1 | 5.37e-05 | 1228 | 148 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A CACNA1D CACNA1E SCN11A DNM1L NCAM1 SHANK3 SLC9A5 GLRB SCN8A SCN10A NINJ1 GNAO1 ATG9A | 7.05e-05 | 583 | 148 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1A CACNA1D CACNA1E SCN11A DNM1L NCAM1 SCN8A SCN10A GNAO1 | 1.63e-04 | 277 | 148 | 9 | GO:0042734 |
| GeneOntologyCellularComponent | C-fiber | 2.96e-04 | 4 | 148 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | cell body | CACNA1A CACNA1B CACNA1D CACNA1E AMFR SCN11A PDE1B NAIP NCAM1 DCTN1 SCN8A VPS13A MTNR1A CACNA1G GNAO1 GNAZ SOS1 | 3.18e-04 | 929 | 148 | 17 | GO:0044297 |
| GeneOntologyCellularComponent | retromer complex | 4.21e-04 | 21 | 148 | 3 | GO:0030904 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A GJD2 GLRB SCN8A SCN10A CACNA1I CACNA1G GNAO1 GNAZ ATP12A | 4.65e-04 | 785 | 148 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1A CACNA1B CACNA1D CACNA1E AMFR SCN11A PDE1B NAIP NCAM1 DCTN1 SCN8A VPS13A MTNR1A CACNA1G SOS1 | 8.75e-04 | 835 | 148 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | cilium | CFAP47 ABCC4 TSPEAR TOGARAM1 LRRC43 TMEM80 DCTN1 ADCY3 SHANK3 DUSP21 VPS13A CFAP61 DNAH6 HYDIN NOTCH2 | 1.80e-03 | 898 | 148 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TBXAS1 KDELR2 AMFR HSD17B7 COPB1 RPN2 DNM1L SRPRA PTDSS2 SSR2 UBA1 CEPT1 VPS13A DISP3 ATG9A NOTCH2 SLC27A5 DGAT1 KPNA2 | 1.98e-03 | 1293 | 148 | 19 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TBXAS1 KDELR2 AMFR HSD17B7 COPB1 RPN2 DNM1L SRPRA PTDSS2 SSR2 UBA1 CEPT1 VPS13A DISP3 ATG9A NOTCH2 SLC27A5 DGAT1 KPNA2 | 2.09e-03 | 1299 | 148 | 19 | GO:0098827 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | KDELR2 ABCC4 MANBA COPB1 GBP7 AP1M2 DNM1L VPS26A UBA1 SLC9A3 SLC9A5 TBC1D4 NPC1L1 VPS13A DISP3 ATG9A LDLRAD4 VPS13B DGAT1 | 2.24e-03 | 1307 | 148 | 19 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | KDELR2 ABCC4 MANBA COPB1 GBP7 AP1M2 DNM1L VPS26A UBA1 SLC9A3 SLC9A5 TBC1D4 NPC1L1 VPS13A DISP3 ATG9A LDLRAD4 VPS13B DGAT1 | 2.61e-03 | 1325 | 148 | 19 | GO:0012506 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TBXAS1 KDELR2 AMFR HSD17B7 COPB1 RPN2 DNM1L SRPRA PTDSS2 SSR2 UBA1 CEPT1 VPS13A DISP3 ATG9A NOTCH2 SLC27A5 DGAT1 KPNA2 | 2.65e-03 | 1327 | 148 | 19 | GO:0042175 |
| MousePheno | abnormal single cell response | 1.04e-08 | 35 | 113 | 7 | MP:0003463 | |
| MousePheno | abnormal channel response | 2.26e-07 | 33 | 113 | 6 | MP:0003484 | |
| MousePheno | absence seizures | 8.45e-06 | 35 | 113 | 5 | MP:0003216 | |
| MousePheno | abnormal action potential | 1.20e-05 | 133 | 113 | 8 | MP:0005402 | |
| MousePheno | nonconvulsive seizures | 1.66e-05 | 40 | 113 | 5 | MP:0000948 | |
| MousePheno | decreased susceptibility to weight gain | DENND5B CACNA1B ADCY3 FABP2 HSPA12A NPC1L1 CACNA1G SLC27A5 DGAT1 | 1.96e-05 | 186 | 113 | 9 | MP:0010182 |
| MousePheno | increased energy expenditure | CACNA1B LGALS12 ADCY3 FABP2 HSPA12A NPC1L1 CACNA1G SLC27A5 DGAT1 | 2.96e-05 | 196 | 113 | 9 | MP:0004889 |
| MousePheno | abnormal spike wave discharge | 3.80e-05 | 24 | 113 | 4 | MP:0008840 | |
| MousePheno | abnormal energy expenditure | CACNA1B FNDC5 LGALS12 ADCY3 FABP2 HSPA12A TBC1D4 NPC1L1 CACNA1G SLC27A5 DGAT1 | 4.54e-05 | 313 | 113 | 11 | MP:0005450 |
| MousePheno | decreased susceptibility to diet-induced obesity | 4.57e-05 | 160 | 113 | 8 | MP:0005659 | |
| MousePheno | abnormal stride length | 5.19e-05 | 82 | 113 | 6 | MP:0012690 | |
| MousePheno | decreased liver cholesterol level | 5.28e-05 | 26 | 113 | 4 | MP:0010026 | |
| MousePheno | abnormal energy homeostasis | CACNA1B FNDC5 LGALS12 ADCY3 FABP2 HSPA12A TBC1D4 NPC1L1 CACNA1G SLC27A5 DGAT1 | 5.87e-05 | 322 | 113 | 11 | MP:0005448 |
| MousePheno | decreased thermal nociceptive threshold | 7.28e-05 | 54 | 113 | 5 | MP:0003998 | |
| MousePheno | abnormal liver cholesterol level | 1.03e-04 | 58 | 113 | 5 | MP:0012776 | |
| MousePheno | abnormal brain wave pattern | 1.65e-04 | 64 | 113 | 5 | MP:0004994 | |
| MousePheno | abnormal excitatory postsynaptic potential | 1.75e-04 | 102 | 113 | 6 | MP:0002912 | |
| MousePheno | abnormal susceptibility to weight gain | DENND5B CACNA1B FNDC5 ADCY3 FABP2 HSPA12A NPC1L1 CACNA1G SLC27A5 DGAT1 | 2.00e-04 | 309 | 113 | 10 | MP:0011117 |
| MousePheno | short stride length | 2.35e-04 | 69 | 113 | 5 | MP:0001407 | |
| MousePheno | abnormal afterhyperpolarization | 3.22e-04 | 17 | 113 | 3 | MP:0003412 | |
| MousePheno | abnormal nervous system electrophysiology | CACNA1A CACNA1B CACNA1D SCN11A GJD2 SHANK3 SCN8A SCN10A CACNA1I CACNA1G | 3.31e-04 | 329 | 113 | 10 | MP:0002272 |
| MousePheno | hyperalgesia | 4.17e-04 | 78 | 113 | 5 | MP:0005407 | |
| MousePheno | abnormal thermal nociception | 4.24e-04 | 168 | 113 | 7 | MP:0002733 | |
| Domain | VDCCAlpha1 | 1.65e-13 | 10 | 144 | 7 | IPR002077 | |
| Domain | Channel_four-helix_dom | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SCN8A SCN10A CACNA1I CACNA1G | 1.72e-11 | 57 | 144 | 10 | IPR027359 |
| Domain | - | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SCN8A SCN10A CACNA1I CACNA1G | 1.72e-11 | 57 | 144 | 10 | 1.20.120.350 |
| Domain | Ca_chan_IQ | 5.27e-10 | 7 | 144 | 5 | SM01062 | |
| Domain | Ca_chan_IQ | 5.27e-10 | 7 | 144 | 5 | PF08763 | |
| Domain | VDCC_a1su_IQ | 5.27e-10 | 7 | 144 | 5 | IPR014873 | |
| Domain | GPHH | 5.27e-10 | 7 | 144 | 5 | PF16905 | |
| Domain | GPHH_dom | 5.27e-10 | 7 | 144 | 5 | IPR031649 | |
| Domain | Ion_trans_dom | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SCN8A SCN10A CACNA1I CACNA1G | 1.86e-08 | 114 | 144 | 10 | IPR005821 |
| Domain | Ion_trans | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A SCN8A SCN10A CACNA1I CACNA1G | 1.86e-08 | 114 | 144 | 10 | PF00520 |
| Domain | NaH_exchanger | 3.64e-05 | 9 | 144 | 3 | IPR004709 | |
| Domain | Na_channel_asu | 5.18e-05 | 10 | 144 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 5.18e-05 | 10 | 144 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 5.18e-05 | 10 | 144 | 3 | PF06512 | |
| Domain | Na/H_exchanger_3/5 | 5.90e-05 | 2 | 144 | 2 | IPR018410 | |
| Domain | GAIN_dom_N | 7.08e-05 | 11 | 144 | 3 | IPR032471 | |
| Domain | Cation/H_exchanger_CPA1 | 7.08e-05 | 11 | 144 | 3 | IPR018422 | |
| Domain | GAIN | 7.08e-05 | 11 | 144 | 3 | PF16489 | |
| Domain | Na_H_Exchanger | 1.54e-04 | 14 | 144 | 3 | PF00999 | |
| Domain | Cation/H_exchanger | 1.54e-04 | 14 | 144 | 3 | IPR006153 | |
| Domain | uDENN | 1.54e-04 | 14 | 144 | 3 | SM00800 | |
| Domain | VDCC_T_a1 | 1.76e-04 | 3 | 144 | 2 | IPR005445 | |
| Domain | uDENN | 1.91e-04 | 15 | 144 | 3 | PF03456 | |
| Domain | DENN | 2.34e-04 | 16 | 144 | 3 | SM00799 | |
| Domain | DENN | 2.34e-04 | 16 | 144 | 3 | PF02141 | |
| Domain | dDENN | 2.34e-04 | 16 | 144 | 3 | PF03455 | |
| Domain | UDENN | 2.34e-04 | 16 | 144 | 3 | PS50946 | |
| Domain | DDENN | 2.34e-04 | 16 | 144 | 3 | PS50947 | |
| Domain | dDENN | 2.34e-04 | 16 | 144 | 3 | SM00801 | |
| Domain | dDENN_dom | 2.34e-04 | 16 | 144 | 3 | IPR005112 | |
| Domain | uDENN_dom | 2.34e-04 | 16 | 144 | 3 | IPR005113 | |
| Domain | DENN | 2.34e-04 | 16 | 144 | 3 | PS50211 | |
| Domain | DENN_dom | 2.34e-04 | 16 | 144 | 3 | IPR001194 | |
| Domain | RUN | 3.36e-04 | 18 | 144 | 3 | SM00593 | |
| Domain | SHR-BD | 3.51e-04 | 4 | 144 | 2 | IPR009543 | |
| Domain | VDCC_L_a1su | 3.51e-04 | 4 | 144 | 2 | IPR005446 | |
| Domain | VPS13_C | 3.51e-04 | 4 | 144 | 2 | PF16909 | |
| Domain | VPS13_C | 3.51e-04 | 4 | 144 | 2 | IPR031645 | |
| Domain | SHR-BD | 3.51e-04 | 4 | 144 | 2 | PF06650 | |
| Domain | LamG | 3.62e-04 | 44 | 144 | 4 | SM00282 | |
| Domain | RUN | 3.97e-04 | 19 | 144 | 3 | PS50826 | |
| Domain | RUN | 3.97e-04 | 19 | 144 | 3 | PF02759 | |
| Domain | Run_dom | 3.97e-04 | 19 | 144 | 3 | IPR004012 | |
| Domain | - | 5.39e-04 | 21 | 144 | 3 | 2.60.60.20 | |
| Domain | PLAT | 5.39e-04 | 21 | 144 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 5.39e-04 | 21 | 144 | 3 | IPR001024 | |
| Domain | PLAT | 5.39e-04 | 21 | 144 | 3 | PS50095 | |
| Domain | Autophagy-rel_C | 5.81e-04 | 5 | 144 | 2 | IPR015412 | |
| Domain | ATG_C | 5.81e-04 | 5 | 144 | 2 | PF09333 | |
| Domain | IQ_motif_EF-hand-BS | 6.60e-04 | 90 | 144 | 5 | IPR000048 | |
| Domain | IQ | 7.66e-04 | 93 | 144 | 5 | PS50096 | |
| Domain | AAA | 8.82e-04 | 144 | 144 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 8.82e-04 | 144 | 144 | 6 | IPR003593 | |
| Domain | Laminin_G | 1.04e-03 | 58 | 144 | 4 | IPR001791 | |
| Domain | DH_1 | 1.42e-03 | 63 | 144 | 4 | PS00741 | |
| Domain | Gprotein_alpha_I | 1.60e-03 | 8 | 144 | 2 | IPR001408 | |
| Domain | Chorein_N | 1.60e-03 | 8 | 144 | 2 | PF12624 | |
| Domain | - | 1.60e-03 | 8 | 144 | 2 | 2.60.40.360 | |
| Domain | VPS13_N | 1.60e-03 | 8 | 144 | 2 | IPR026854 | |
| Domain | RhoGEF | 1.88e-03 | 68 | 144 | 4 | SM00325 | |
| Domain | PapD-like | 2.05e-03 | 9 | 144 | 2 | IPR008962 | |
| Domain | Ptc/Disp | 2.05e-03 | 9 | 144 | 2 | IPR003392 | |
| Domain | Patched | 2.05e-03 | 9 | 144 | 2 | PF02460 | |
| Domain | RhoGEF | 2.10e-03 | 70 | 144 | 4 | PF00621 | |
| Domain | DH_2 | 2.10e-03 | 70 | 144 | 4 | PS50010 | |
| Domain | IQ | 2.21e-03 | 71 | 144 | 4 | PF00612 | |
| Domain | - | 2.21e-03 | 71 | 144 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.21e-03 | 71 | 144 | 4 | IPR000219 | |
| Domain | GPS | 2.25e-03 | 34 | 144 | 3 | SM00303 | |
| Domain | GPS | 2.45e-03 | 35 | 144 | 3 | PF01825 | |
| Domain | EGF_CA | 2.56e-03 | 122 | 144 | 5 | SM00179 | |
| Domain | GPS | 2.66e-03 | 36 | 144 | 3 | PS50221 | |
| Domain | EGF-like_Ca-bd_dom | 2.75e-03 | 124 | 144 | 5 | IPR001881 | |
| Domain | GPS | 2.88e-03 | 37 | 144 | 3 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 3.11e-03 | 38 | 144 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 3.60e-03 | 40 | 144 | 3 | PF02210 | |
| Domain | SSD | 4.36e-03 | 13 | 144 | 2 | IPR000731 | |
| Domain | SSD | 4.36e-03 | 13 | 144 | 2 | PS50156 | |
| Domain | - | DDX19B ABCC4 MYO1E GBP7 NAIP DNM1L SRPRA TOR4A GNAO1 GNAZ DNAH6 SNRNP200 HYDIN | 5.13e-03 | 746 | 144 | 13 | 3.40.50.300 |
| Domain | P-loop_NTPase | DDX19B ABCC4 MYO1E GBP7 NAIP DNM1L SRPRA TOR4A GNAO1 GNAZ DNAH6 SNRNP200 HYDIN MYO16 | 5.94e-03 | 848 | 144 | 14 | IPR027417 |
| Domain | - | 6.27e-03 | 95 | 144 | 4 | 2.60.120.200 | |
| Domain | GproteinA_insert | 6.60e-03 | 16 | 144 | 2 | IPR011025 | |
| Domain | - | 6.60e-03 | 16 | 144 | 2 | 1.10.400.10 | |
| Domain | G-alpha | 6.60e-03 | 16 | 144 | 2 | PF00503 | |
| Domain | G_alpha | 6.60e-03 | 16 | 144 | 2 | SM00275 | |
| Domain | 7tm_2 | 6.75e-03 | 50 | 144 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.75e-03 | 50 | 144 | 3 | PS00650 | |
| Domain | ConA-like_dom | 7.09e-03 | 219 | 144 | 6 | IPR013320 | |
| Domain | Gprotein_alpha_su | 7.44e-03 | 17 | 144 | 2 | IPR001019 | |
| Domain | ASX_HYDROXYL | 7.50e-03 | 100 | 144 | 4 | PS00010 | |
| Domain | - | 7.56e-03 | 222 | 144 | 6 | 1.25.10.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.14e-10 | 23 | 114 | 7 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 8.00e-10 | 25 | 114 | 7 | M47948 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S PDE1B ADCY3 PHKA2 P2RX5 CACNA1I CACNA1G | 1.99e-07 | 178 | 114 | 11 | M2890 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.28e-06 | 11 | 114 | 4 | M47958 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GJD2 ADCY3 GNAO1 GNAZ | 2.92e-06 | 147 | 114 | 9 | MM15854 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GJD2 ADCY3 GNAO1 GNAZ | 3.64e-06 | 151 | 114 | 9 | M39329 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.01e-05 | 6 | 114 | 3 | M47762 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.14e-05 | 63 | 114 | 6 | M11187 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.12e-05 | 42 | 114 | 5 | M7169 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.70e-05 | 47 | 114 | 5 | M19708 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 4.18e-05 | 9 | 114 | 3 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 4.18e-05 | 9 | 114 | 3 | MM15079 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 8.11e-05 | 11 | 114 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 8.11e-05 | 11 | 114 | 3 | M26913 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.53e-04 | 63 | 114 | 5 | M8 | |
| Pathway | WP_KENNEDY_PATHWAY | 1.76e-04 | 14 | 114 | 3 | MM15980 | |
| Pathway | WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS | 1.76e-04 | 14 | 114 | 3 | M39620 | |
| Pathway | WP_ENTEROCYTE_CHOLESTEROL_METABOLISM | 1.96e-04 | 36 | 114 | 4 | M48067 | |
| Pathway | WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS | 7.09e-04 | 22 | 114 | 3 | M39362 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 8.06e-04 | 90 | 114 | 5 | MM15882 | |
| Pathway | WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS | 8.11e-04 | 23 | 114 | 3 | MM15993 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 8.47e-04 | 91 | 114 | 5 | M39426 | |
| Pathway | WP_MAPK_SIGNALING | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S CACNA1I CACNA1G SOS1 | 8.61e-04 | 246 | 114 | 8 | M39597 |
| Pubmed | 1.49e-13 | 8 | 148 | 6 | 28330839 | ||
| Pubmed | 4.46e-13 | 9 | 148 | 6 | 16382099 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN11A KCNJ1 SCN8A SCN10A CACNA1G | 4.78e-10 | 139 | 148 | 10 | 16985003 |
| Pubmed | 1.57e-09 | 5 | 148 | 4 | 11296258 | ||
| Pubmed | 1.57e-09 | 5 | 148 | 4 | 15451373 | ||
| Pubmed | 3.78e-09 | 15 | 148 | 5 | 20188150 | ||
| Pubmed | 3.78e-09 | 15 | 148 | 5 | 24453333 | ||
| Pubmed | 1.09e-08 | 7 | 148 | 4 | 12900400 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.32e-08 | 38 | 148 | 6 | 30786075 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 7.55e-08 | 3 | 148 | 3 | 24523520 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 3.01e-07 | 4 | 148 | 3 | 37141091 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 3.01e-07 | 4 | 148 | 3 | 32616470 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 8825650 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 12060068 | ||
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 16029194 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 1.50e-06 | 6 | 148 | 3 | 35324301 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 23711479 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.50e-06 | 6 | 148 | 3 | 12827191 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 9238069 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | FNDC3B AMFR ABCC4 COPB1 RPN2 TMEM115 SRPRA TOR4A PTDSS2 CEPT1 CLPTM1 NOTCH2 | 1.67e-06 | 499 | 148 | 12 | 22810586 |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 23677982 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 2.61e-06 | 7 | 148 | 3 | 35176221 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 12576672 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TRAF7 ABCC4 MANBA RPN2 SRPRA TSN PTDSS2 SSR2 NCAPG2 CELSR1 UBA1 TBC1D4 CELSR2 P2RX5 CLPTM1 TMEM131 NOTCH2 DGAT1 | 3.84e-06 | 1201 | 148 | 18 | 35696571 |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 19619496 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 16382098 | ||
| Pubmed | 9.32e-06 | 113 | 148 | 6 | 30352685 | ||
| Pubmed | DDX19B AMFR ABCC4 COPB1 RPN2 DNM1L NCAM1 DCTN1 NCAPG2 ADCY3 CSE1L CLPTM1 ETNK1 ATG9A NONO NOTCH2 KPNA2 | 1.06e-05 | 1168 | 148 | 17 | 19946888 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 1.17e-05 | 33 | 148 | 4 | 22357600 | |
| Pubmed | KDELR2 EFCAB5 CACNA1E SCN11A RPN2 SSR2 LRRC43 DCTN1 RUNDC3A WDR75 VPS13A MTNR1A PLXNA4 SMARCC2 PDIA2 GNAO1 ATP12A DNAH6 NONO | 1.27e-05 | 1442 | 148 | 19 | 35575683 | |
| Pubmed | Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethality. | 1.35e-05 | 71 | 148 | 5 | 36305789 | |
| Pubmed | DENND5B HSD17B7 GJD2 ARHGEF28 OR9I1 DNM1L EZH2 DCTN1 NCAPG2 UBA1 CEPT1 ODR4 AHR NKTR ATG9A SOS1 KPNA2 SLC16A10 | 1.49e-05 | 1327 | 148 | 18 | 32694731 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.79e-05 | 344 | 148 | 9 | 36282215 | |
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 1.80e-05 | 2 | 148 | 2 | 29970412 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24144460 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.80e-05 | 2 | 148 | 2 | 23426690 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 38964745 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26627919 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23292348 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23376566 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28450535 | ||
| Pubmed | Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. | 1.80e-05 | 2 | 148 | 2 | 27896923 | |
| Pubmed | Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family. | 1.80e-05 | 2 | 148 | 2 | 17418573 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 10066808 | ||
| Pubmed | SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons. | 1.80e-05 | 2 | 148 | 2 | 27916453 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 38155373 | ||
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 1.80e-05 | 2 | 148 | 2 | 28978442 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31534133 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12598940 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 36635272 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11395521 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18399542 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16381801 | ||
| Pubmed | Determination of the functional domain organization of the importin alpha nuclear import factor. | 1.80e-05 | 2 | 148 | 2 | 9786944 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33144668 | ||
| Pubmed | Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. | 1.80e-05 | 2 | 148 | 2 | 8071363 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19931571 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34930944 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16857712 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30058071 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21789999 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20547676 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 1.80e-05 | 2 | 148 | 2 | 12074836 | |
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 1.80e-05 | 2 | 148 | 2 | 25959819 | |
| Pubmed | The signal recognition particle receptor is a complex that contains two distinct polypeptide chains. | 1.80e-05 | 2 | 148 | 2 | 3021779 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15050706 | ||
| Pubmed | COPB1 RPN2 DNM1L DCTN1 CBS UBA1 TBC1D4 CSE1L WDR75 NONO SNRNP200 KPNA2 | 1.98e-05 | 638 | 148 | 12 | 33239621 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRAF7 MYO1E HECTD4 OBSCN TOR4A FRYL DCTN1 CELSR1 CELSR2 SCN8A WDR90 ATG9A DENND5A GNAZ ALOX5 NOTCH2 | 2.09e-05 | 1105 | 148 | 16 | 35748872 |
| Pubmed | 2.66e-05 | 14 | 148 | 3 | 21525298 | ||
| Pubmed | 3.22e-05 | 285 | 148 | 8 | 32838362 | ||
| Pubmed | DDX19B ARHGEF28 COPB1 RPN2 SRPRA CBS GRSF1 S100A8 UBA1 CSE1L SMARCC2 NKTR SOS1 KPNA2 | 3.95e-05 | 916 | 148 | 14 | 32203420 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | IMPA2 SRPRA TSN PTDSS2 VPS26A NCAPG2 SLC9A1 CELSR2 ODR4 VPS13A AHR NIPA1 ATG9A ATP12A NOTCH2 | 5.03e-05 | 1061 | 148 | 15 | 33845483 |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 20551905 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 5.38e-05 | 3 | 148 | 2 | 23488970 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 24966091 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 21406960 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 29466725 | ||
| Pubmed | Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. | 5.38e-05 | 3 | 148 | 2 | 20395535 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 30395542 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 5.38e-05 | 3 | 148 | 2 | 11230107 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 17767505 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 5.38e-05 | 3 | 148 | 2 | 28972185 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 34837834 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 2173707 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 38999942 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 27353765 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 11677057 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 30425165 | ||
| Pubmed | Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. | 5.38e-05 | 3 | 148 | 2 | 29497094 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 11897840 | ||
| Pubmed | Interferon-gamma suppresses Na+ -H+ exchanger in cultured human endolymphatic sac epithelial cells. | 5.38e-05 | 3 | 148 | 2 | 19479940 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 5.38e-05 | 3 | 148 | 2 | 29208674 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 5.38e-05 | 3 | 148 | 2 | 26507659 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 11358967 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 10506152 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 23338940 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 32154672 | ||
| Interaction | SCN11A interactions | 5.45e-10 | 15 | 143 | 6 | int:SCN11A | |
| Interaction | CACNA1B interactions | 2.23e-07 | 37 | 143 | 6 | int:CACNA1B | |
| Interaction | CACNA1D interactions | 6.39e-07 | 24 | 143 | 5 | int:CACNA1D | |
| Interaction | SCN10A interactions | 7.72e-07 | 11 | 143 | 4 | int:SCN10A | |
| Interaction | SCN5A interactions | 9.71e-07 | 47 | 143 | 6 | int:SCN5A | |
| Interaction | SCN1A interactions | 1.74e-06 | 29 | 143 | 5 | int:SCN1A | |
| Interaction | NALCN interactions | 2.30e-06 | 14 | 143 | 4 | int:NALCN | |
| Interaction | SCN9A interactions | 1.32e-05 | 21 | 143 | 4 | int:SCN9A | |
| Interaction | DENND5A interactions | 5.03e-05 | 29 | 143 | 4 | int:DENND5A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.38e-04 | 345 | 148 | 7 | chr11q12 | |
| Cytoband | 22q13.3 | 1.54e-04 | 6 | 148 | 2 | 22q13.3 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.19e-11 | 26 | 99 | 7 | 253 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.31e-05 | 9 | 99 | 3 | 1203 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 8.87e-05 | 3 | 99 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 8.87e-05 | 3 | 99 | 2 | 1189 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.36e-04 | 25 | 99 | 3 | 504 | |
| GeneFamily | Cadherin related | 3.83e-03 | 17 | 99 | 2 | 24 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 4.78e-03 | 19 | 99 | 2 | 909 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.68e-03 | 66 | 99 | 3 | 722 | |
| GeneFamily | EF-hand domain containing | 7.10e-03 | 219 | 99 | 5 | 863 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP | HSD17B7 EZH2 PPWD1 GRSF1 FANCC CELSR2 SCN8A SNRNP200 SLC27A5 | 1.87e-06 | 198 | 147 | 9 | M3449 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | CACNA1A CACNA1B CACNA1E OBSCN NCAM1 CELSR2 PLXNA4 PDIA2 TMEM131 GNAZ MYO16 | 1.30e-05 | 389 | 147 | 11 | M39102 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A CACNA1E ENOX1 PDE1B FNDC5 NCAM1 SHANK3 HSPA12A FAT2 RUNDC3A SCN8A PLXNA4 SMARCC2 CACNA1I CACNA1G NIPA1 GNAO1 GNAZ HYDIN | 1.44e-05 | 1106 | 147 | 19 | M39071 |
| Coexpression | GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN | 1.80e-05 | 200 | 147 | 8 | M5086 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 196 | 145 | 8 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 196 | 145 | 8 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.02e-07 | 199 | 145 | 8 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 174 | 145 | 7 | 28ec25767bbd4fd898738f9f4d2b585dc91b5adf | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.89e-06 | 177 | 145 | 7 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.28e-06 | 182 | 145 | 7 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.73e-06 | 187 | 145 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 3.36e-06 | 193 | 145 | 7 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 3.59e-06 | 195 | 145 | 7 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 3.59e-06 | 195 | 145 | 7 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | nucseq-Immune-Immune_Myeloid|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.97e-06 | 198 | 145 | 7 | d0ad9ef51dd9d0135931fa627144721ad9aa5397 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.11e-06 | 199 | 145 | 7 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.81e-06 | 144 | 145 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 155 | 145 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 166 | 145 | 6 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 167 | 145 | 6 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.88e-05 | 168 | 145 | 6 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 170 | 145 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 2.07e-05 | 171 | 145 | 6 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 172 | 145 | 6 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 176 | 145 | 6 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 176 | 145 | 6 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 2.52e-05 | 177 | 145 | 6 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 180 | 145 | 6 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 180 | 145 | 6 | d8135f73a89b97168f2048258f4648e23536ece4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-05 | 181 | 145 | 6 | 166ff44fcc0a2943b7f485ea8a9c314964e013bb | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.23e-05 | 185 | 145 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 185 | 145 | 6 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 186 | 145 | 6 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 186 | 145 | 6 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 186 | 145 | 6 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 187 | 145 | 6 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.53e-05 | 188 | 145 | 6 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 189 | 145 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 3.64e-05 | 189 | 145 | 6 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.64e-05 | 189 | 145 | 6 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 3.64e-05 | 189 | 145 | 6 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.75e-05 | 190 | 145 | 6 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 191 | 145 | 6 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 191 | 145 | 6 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | Neuroendocrine|World / Class top | 3.97e-05 | 192 | 145 | 6 | 0199da3ef9ddb6673e9aa41f346f374838aec182 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 193 | 145 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.09e-05 | 193 | 145 | 6 | bd82961502db42a0c862d3a29a2babe8032384c8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 193 | 145 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 193 | 145 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.21e-05 | 194 | 145 | 6 | 3c30f86806f6a0f43e6103ad7009f4c6a90e011c | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 4.21e-05 | 194 | 145 | 6 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | Control-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 4.21e-05 | 194 | 145 | 6 | c35bf04d5e7450cb6679a036fcabb1b28f409f29 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 4.33e-05 | 195 | 145 | 6 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.33e-05 | 195 | 145 | 6 | d07a8cfecf7a54cf6274565b1649e735abb79c87 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 4.33e-05 | 195 | 145 | 6 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.39e-05 | 60 | 145 | 4 | aa75fef294803ec6396c7d2c1f51d52bc4a5b43f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.39e-05 | 60 | 145 | 4 | 069fbabfd0e48e5809ff01a026439fd0bd017779 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.45e-05 | 196 | 145 | 6 | 7dff78ff7b2b333680de1c9ca78190770574d796 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 4.45e-05 | 196 | 145 | 6 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.45e-05 | 196 | 145 | 6 | 5bcb57c57d5da0440220a1133a96aa89407bd871 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-05 | 197 | 145 | 6 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-05 | 197 | 145 | 6 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 197 | 145 | 6 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 4.71e-05 | 198 | 145 | 6 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.71e-05 | 198 | 145 | 6 | 9aced8bdb56ee52866a0a9766a84336961bc4443 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 198 | 145 | 6 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-05 | 199 | 145 | 6 | 514dbf128b6832b1cbd65be023d4fe02400e8dec | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 4.85e-05 | 199 | 145 | 6 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.98e-05 | 200 | 145 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.98e-05 | 200 | 145 | 6 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.98e-05 | 200 | 145 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 200 | 145 | 6 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.49e-05 | 133 | 145 | 5 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 145 | 145 | 5 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 149 | 145 | 5 | 5a5e9660f7d9b527f50a92d94d4c0c8aedb82c0b | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 154 | 145 | 5 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.49e-04 | 154 | 145 | 5 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 154 | 145 | 5 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.58e-04 | 156 | 145 | 5 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | control-B_cell|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.63e-04 | 157 | 145 | 5 | 1269b55f2ef6a493f6116b131cc5cc7b8897d63e | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 158 | 145 | 5 | 9fd77ebdd1babf1c85a85d38d9a15858ab08bc84 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 158 | 145 | 5 | 0edd9b005875f9a4f5446f5d5161f8ba63860793 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 159 | 145 | 5 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 160 | 145 | 5 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 161 | 145 | 5 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-04 | 161 | 145 | 5 | d1f2e5245c7c247b684f48f9f877e149a3ee7c06 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 161 | 145 | 5 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 162 | 145 | 5 | d0ffebf5adee8a3ac9b81a4b793184f54010489a | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.89e-04 | 162 | 145 | 5 | a0367e9af78e4699b9d89d3e0597589e644f844c | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.89e-04 | 162 | 145 | 5 | d007ec42d6458431f6c490df61de7a9caef857f0 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.89e-04 | 162 | 145 | 5 | 65549ffdbfe8619693345db78e6ddbdde7b742c9 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 163 | 145 | 5 | e04de78a52cc886623689a913f7852200a77605b | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.94e-04 | 163 | 145 | 5 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 163 | 145 | 5 | 8509b87748ec460992ae6cedbb155e1c6f6e2e48 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass | 2.00e-04 | 164 | 145 | 5 | 06db4cc064f0765c481ce880207823872c27bfa9 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.00e-04 | 164 | 145 | 5 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 165 | 145 | 5 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 167 | 145 | 5 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 167 | 145 | 5 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 167 | 145 | 5 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 168 | 145 | 5 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 168 | 145 | 5 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 2.24e-04 | 168 | 145 | 5 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-04 | 169 | 145 | 5 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| Computational | Genes in the cancer module 557. | 8.63e-05 | 11 | 89 | 3 | MODULE_557 | |
| Drug | 3,4-dihydroquinazoline | 6.04e-11 | 6 | 146 | 5 | CID000583065 | |
| Drug | Verapamil | 4.76e-10 | 16 | 146 | 6 | DB00661 | |
| Drug | CNS 1145 | 1.43e-09 | 33 | 146 | 7 | CID000190902 | |
| Drug | IHC-64 | 1.43e-09 | 33 | 146 | 7 | CID000162753 | |
| Drug | AC1L2VU3 | 7.73e-09 | 12 | 146 | 5 | CID000129572 | |
| Drug | AC1L1TJF | TBXAS1 CACNA1A CACNA1B CACNA1D CACNA1E ADCY3 CACNA1I CACNA1G | 9.89e-09 | 66 | 146 | 8 | CID000003377 |
| Drug | AC1L2AC7 | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S TONSL CACNA1I CACNA1G | 1.42e-08 | 69 | 146 | 8 | CID000068733 |
| Drug | NSC7524 | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S PDE1B CBS ADCY3 SCN10A CACNA1I CACNA1G | 2.70e-08 | 182 | 146 | 11 | CID000005657 |
| Drug | nisoldipine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADGRL4 CACNA1I CACNA1G | 3.78e-08 | 78 | 146 | 8 | CID000004499 |
| Drug | pentasulfane | 4.18e-08 | 16 | 146 | 5 | CID000448216 | |
| Drug | myo-inositol | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S AMFR GALR1 IMPA2 DNM1L ADCY3 ADGRL4 CEPT1 TBC1D4 CSE1L P2RX5 MS4A1 CACNA1I CACNA1G GNAO1 GNAZ ALOX5 | 5.46e-08 | 811 | 146 | 21 | CID000000892 |
| Drug | AC1NBU2S | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S TONSL CACNA1I CACNA1G ALOX5 | 6.56e-08 | 117 | 146 | 9 | CID004473765 |
| Drug | Cinildipine | 6.88e-08 | 56 | 146 | 7 | CID000002752 | |
| Drug | nilvadipine | 1.12e-07 | 60 | 146 | 7 | CID000004494 | |
| Drug | potassium | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GJD2 GALR1 IMPA2 CBS ADCY3 ZACN SLC9A1 SLC9A3 SLC9A5 KCNJ1 CLPTM1 TONSL SCN10A CACNA1I CACNA1G ATP12A SOS1 SLC16A10 | 1.18e-07 | 1008 | 146 | 23 | CID000000813 |
| Drug | IAA-94 | 1.26e-07 | 61 | 146 | 7 | CID000003667 | |
| Drug | lercanidipine | 1.58e-07 | 63 | 146 | 7 | CID000065866 | |
| Drug | lavendustin A | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADGRL4 GLRB AHR CACNA1I CACNA1G | 1.61e-07 | 171 | 146 | 10 | CID000003894 |
| Drug | valproate | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S IMPA2 TSPEAR NCAM1 EZH2 GLRB TONSL CACNA1I CACNA1G ALOX5 | 1.74e-07 | 381 | 146 | 14 | CID000003121 |
| Drug | riluzole | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GLRB SCN10A NINJ1 CACNA1I CACNA1G | 1.90e-07 | 174 | 146 | 10 | CID000005070 |
| Drug | Cinnarizine | 1.99e-07 | 9 | 146 | 4 | DB00568 | |
| Drug | nitrendipine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ZACN CACNA1I CACNA1G | 2.28e-07 | 98 | 146 | 8 | CID000004507 |
| Drug | gallopamil | 2.43e-07 | 67 | 146 | 7 | CID000001234 | |
| Drug | isradipine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN10A CACNA1I CACNA1G | 2.67e-07 | 100 | 146 | 8 | CID000003784 |
| Drug | U46619 | TBXAS1 CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S PDE1B ADCY3 CACNA1I CACNA1G GNAZ ALOX5 | 3.26e-07 | 285 | 146 | 12 | CID000005618 |
| Drug | CAS 298-57-7 | 4.41e-07 | 73 | 146 | 7 | CID000002761 | |
| Drug | baclofen | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADCY3 KCNJ1 GLRB CACNA1I CACNA1G | 4.50e-07 | 191 | 146 | 10 | CID000002284 |
| Drug | NSC759576 | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADCY3 TONSL CACNA1I CACNA1G SOS1 | 4.50e-07 | 191 | 146 | 10 | CID000003075 |
| Drug | carbachol | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GALR1 IMPA2 TSPEAR ADCY3 ADGRL4 SLC9A1 KCNJ1 TONSL AHR CACNA1I CACNA1G GNAO1 GNAZ | 4.57e-07 | 688 | 146 | 18 | CID000002551 |
| Drug | ethosuximide | 4.85e-07 | 74 | 146 | 7 | CID000003291 | |
| Drug | Mibefradil | 5.17e-07 | 11 | 146 | 4 | DB01388 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 7.61e-07 | 79 | 146 | 7 | CID005287890 | |
| Drug | KW-3049 | 7.90e-07 | 50 | 146 | 6 | CID000002324 | |
| Drug | lamotrigine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN10A CACNA1I CACNA1G | 8.35e-07 | 116 | 146 | 8 | CID000003878 |
| Drug | AC 110 | 1.03e-06 | 4 | 146 | 3 | CID000022860 | |
| Drug | capsazepine | 1.16e-06 | 84 | 146 | 7 | CID002733484 | |
| Drug | GTP[S] | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GALR1 COPB1 DNM1L ADCY3 SLC9A1 KCNJ1 MTNR1A SCN10A CACNA1I GNAO1 GNAZ | 1.34e-06 | 591 | 146 | 16 | CID000001764 |
| Drug | gabapentin | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S KCNJ1 SCN10A CACNA1I CACNA1G | 1.50e-06 | 169 | 146 | 9 | CID000003446 |
| Drug | felodipine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S PDE1B ADGRL4 CACNA1I CACNA1G | 1.50e-06 | 169 | 146 | 9 | CID000003333 |
| Drug | AC1L1JG6 | 1.55e-06 | 14 | 146 | 4 | CID000005026 | |
| Drug | phenytoin | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S TONSL AOC3 SCN10A CACNA1I CACNA1G | 1.56e-06 | 219 | 146 | 10 | CID000001775 |
| Drug | bepridil | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN10A CACNA1I CACNA1G | 1.57e-06 | 126 | 146 | 8 | CID000002351 |
| Drug | pimozide | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S VPS13A CACNA1I CACNA1G | 1.66e-06 | 127 | 146 | 8 | CID000016362 |
| Drug | aldosterone | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADGRL4 SLC9A1 SLC9A3 KCNJ1 TONSL AOC3 CACNA1I CACNA1G | 1.77e-06 | 397 | 146 | 13 | CID000005839 |
| Drug | papaverine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S PDE1B ADCY3 CACNA1I CACNA1G | 2.09e-06 | 176 | 146 | 9 | CID000004680 |
| Drug | butamben | 2.10e-06 | 15 | 146 | 4 | CID000002482 | |
| Drug | almagel | 2.56e-06 | 5 | 146 | 3 | CID003080942 | |
| Drug | manidipine | 2.66e-06 | 95 | 146 | 7 | CID000004008 | |
| Drug | lanthanum | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADCY3 CACNA1I CACNA1G | 2.78e-06 | 136 | 146 | 8 | CID000023926 |
| Drug | isotetrandrine | 3.06e-06 | 97 | 146 | 7 | CID000005422 | |
| Drug | octylmethoxycinnamate | 3.27e-06 | 139 | 146 | 8 | ctd:C118580 | |
| Drug | verapamil | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ABCC4 ADCY3 ADGRL4 SLC9A1 KCNJ1 SCN10A CACNA1I CACNA1G ALOX5 | 3.43e-06 | 490 | 146 | 14 | CID000002520 |
| Drug | dihydropyridine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ACOT12 SLC9A1 CACNA1I CACNA1G | 4.46e-06 | 193 | 146 | 9 | CID000104822 |
| Drug | nicardipine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S PDIA2 CACNA1I CACNA1G | 4.48e-06 | 145 | 146 | 8 | CID000004473 |
| Drug | Dantrolene-13C3 | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GALR1 CACNA1I CACNA1G | 4.48e-06 | 145 | 146 | 8 | CID000002951 |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ABCC4 PDE1B EZH2 ADCY3 PHKA2 SLC9A3 MTNR1A CACNA1I CACNA1G ALOX5 | 4.77e-06 | 577 | 146 | 15 | CID000000295 |
| Drug | alpha-sialylcholesterol | 5.09e-06 | 6 | 146 | 3 | CID000133976 | |
| Drug | loperamide | 5.20e-06 | 105 | 146 | 7 | CID000003954 | |
| Drug | barium | CACNA1A CACNA1B CACNA1E CACNA1S NDUFB5 KCNJ1 CACNA1I CACNA1G | 5.21e-06 | 148 | 146 | 8 | CID000104810 |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 5.49e-06 | 198 | 146 | 9 | 4790_UP | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | TMPRSS15 GJD2 ARHGEF28 TOR4A S100A8 RUNDC3A SCN10A CACNA1I LDLRAD4 | 5.72e-06 | 199 | 146 | 9 | 4973_UP |
| Drug | Bay K 8644 | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADCY3 CACNA1I CACNA1G | 5.76e-06 | 150 | 146 | 8 | CID000002303 |
| Drug | procaine | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S SCN10A CACNA1I CACNA1G | 6.66e-06 | 153 | 146 | 8 | CID000004914 |
| Drug | Barium | 6.92e-06 | 72 | 146 | 6 | ctd:D001464 | |
| Drug | Amlodipine | 8.87e-06 | 7 | 146 | 3 | DB00381 | |
| Drug | APMPA | 8.87e-06 | 7 | 146 | 3 | CID000512300 | |
| Drug | AC1L1KC5 | CACNA1A CACNA1B KDELR2 CACNA1D CACNA1E CACNA1S NAIP PTDSS2 ADCY3 SLC9A1 AHR CACNA1I CACNA1G ALOX5 | 1.06e-05 | 541 | 146 | 14 | CID000005428 |
| Drug | NiCl2 | 1.19e-05 | 119 | 146 | 7 | CID000024385 | |
| Drug | gamma-aminobutyric acid | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S GJD2 FANCC ZACN GLRB VPS13A AOC3 CACNA1I CACNA1G | 1.20e-05 | 474 | 146 | 13 | CID000000119 |
| Drug | Sodium | 1.69e-05 | 84 | 146 | 6 | ctd:D012964 | |
| Drug | amlodipine | 1.72e-05 | 126 | 146 | 7 | CID000002162 | |
| Drug | Linuron | 1.91e-05 | 128 | 146 | 7 | ctd:D008044 | |
| Drug | enzacamene | 2.01e-05 | 129 | 146 | 7 | ctd:C038939 | |
| Drug | phosphatidylethanolamine | 2.11e-05 | 9 | 146 | 3 | CID000114944 | |
| Drug | tetradotoxin | CACNA1A CACNA1B CACNA1D CACNA1E SCN11A GALR1 S100A8 GLRB SCN8A SCN10A CACNA1I CACNA1G | 2.13e-05 | 428 | 146 | 12 | CID000020382 |
| Drug | Barium permanganate | 2.45e-05 | 133 | 146 | 7 | CID000024587 | |
| Drug | mAHP | 2.54e-05 | 27 | 146 | 4 | CID000220531 | |
| Drug | 2-amino-4-phosphonobutyric acid | 2.67e-05 | 91 | 146 | 6 | CID000002207 | |
| Drug | isoproterenol | CACNA1A CACNA1B CACNA1D SCN11A PDE1B MYO1E LGALS12 ADCY3 ADGRL4 S100A8 TBC1D4 P2RX5 TONSL SCN10A GNAO1 | 2.72e-05 | 669 | 146 | 15 | CID000003779 |
| Drug | AC1NUZ8M | 2.84e-05 | 92 | 146 | 6 | CID000073211 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADCY3 PHKA2 SLC9A5 CACNA1I CACNA1G | 3.10e-05 | 308 | 146 | 10 | CID000001915 |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.45e-05 | 192 | 146 | 8 | 4144_DN | |
| Drug | halothane | CACNA1A CACNA1B CACNA1D CACNA1E CACNA1S ADCY3 GLRB AHR CACNA1I CACNA1G | 3.65e-05 | 314 | 146 | 10 | CID000003562 |
| Drug | etorphine | 3.84e-05 | 59 | 146 | 5 | CID000026721 | |
| Drug | homovanillic acid | 3.84e-05 | 97 | 146 | 6 | CID000001738 | |
| Drug | isovalerate | 3.90e-05 | 143 | 146 | 7 | CID000010430 | |
| Drug | aristolactam AII | 4.08e-05 | 2 | 146 | 2 | CID000148657 | |
| Drug | alkosin | 4.08e-05 | 2 | 146 | 2 | CID005488638 | |
| Drug | norcepharadione B | 4.08e-05 | 2 | 146 | 2 | CID000189168 | |
| Drug | piperolactam A | 4.08e-05 | 2 | 146 | 2 | CID003081016 | |
| Drug | leys | 4.10e-05 | 11 | 146 | 3 | CID000484683 | |
| Drug | EBNs | 4.10e-05 | 11 | 146 | 3 | CID000150695 | |
| Drug | Felodipine | 4.10e-05 | 11 | 146 | 3 | DB01023 | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 4.14e-05 | 197 | 146 | 8 | 7061_DN | |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A | 4.14e-05 | 197 | 146 | 8 | 6842_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 4.14e-05 | 197 | 146 | 8 | 5076_UP | |
| Drug | AC1MBZ1C | CACNA1A CACNA1B CACNA1D CACNA1E PDE1B ADCY3 ADGRL4 SLC9A1 SLC9A3 SLC9A5 TONSL | 4.19e-05 | 387 | 146 | 11 | CID000003541 |
| Drug | nimodipine | 4.26e-05 | 145 | 146 | 7 | CID000004497 | |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 3976_UP | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A | 4.45e-05 | 199 | 146 | 8 | 6452_UP | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.11e-07 | 3 | 143 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 4.44e-07 | 4 | 143 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.11e-06 | 5 | 143 | 3 | DOID:585 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.38e-06 | 163 | 143 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 3.85e-06 | 7 | 143 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.37e-05 | 12 | 143 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 2.46e-05 | 35 | 143 | 4 | EFO_0004458, EFO_0004611 | |
| Disease | susceptibility to scarlet fever measurement | 4.21e-05 | 79 | 143 | 5 | EFO_0008409 | |
| Disease | coffee consumption, cups of coffee per day measurement | 5.96e-05 | 16 | 143 | 3 | EFO_0004330, EFO_0006782 | |
| Disease | Cohen syndrome (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Primary Erythermalgia | 6.97e-05 | 3 | 143 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 6.97e-05 | 3 | 143 | 2 | C1833661 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.39e-04 | 4 | 143 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Heart Block | 1.39e-04 | 4 | 143 | 2 | C0018794 | |
| Disease | Auriculo-Ventricular Dissociation | 1.39e-04 | 4 | 143 | 2 | C0004331 | |
| Disease | Mood Disorders | 1.75e-04 | 168 | 143 | 6 | C0525045 | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 2.31e-04 | 5 | 143 | 2 | EFO_0020474 | |
| Disease | L lactate dehydrogenase measurement | 2.67e-04 | 26 | 143 | 3 | EFO_0004808 | |
| Disease | neural cell adhesion molecule 1, 120 kda isoform measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0020593 | |
| Disease | Epileptic encephalopathy | 4.11e-04 | 30 | 143 | 3 | C0543888 | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 4.54e-04 | 31 | 143 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 4.82e-04 | 7 | 143 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Congenital Pain Insensitivity | 4.82e-04 | 7 | 143 | 2 | C0002768 | |
| Disease | Solid Neoplasm | 4.82e-04 | 7 | 143 | 2 | C0280100 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.82e-04 | 7 | 143 | 2 | C0020075 | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 4.82e-04 | 7 | 143 | 2 | EFO_0801657 | |
| Disease | social communication impairment | 4.99e-04 | 32 | 143 | 3 | EFO_0005427 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 6.41e-04 | 8 | 143 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 6.41e-04 | 8 | 143 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 6.99e-04 | 144 | 143 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 8.06e-04 | 224 | 143 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | corticobasal degeneration disorder | 8.21e-04 | 9 | 143 | 2 | MONDO_0022308 | |
| Disease | cups of coffee per day measurement | 9.66e-04 | 40 | 143 | 3 | EFO_0006782 | |
| Disease | end stage renal disease (is_implicated_in) | 1.04e-03 | 41 | 143 | 3 | DOID:783 (is_implicated_in) | |
| Disease | neutrophil count | CACNA1A KDELR2 CPAMD8 MYO1E HECTD4 NAIP WDR27 GCKR SSR2 CBS ADGRL4 SLC9A1 CEPT1 GNAO1 HYDIN NOTCH2 | 1.11e-03 | 1382 | 143 | 16 | EFO_0004833 |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.25e-03 | 11 | 143 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Diarrhea | 1.25e-03 | 11 | 143 | 2 | C0011991 | |
| Disease | coffee consumption measurement, tea consumption measurement | 1.28e-03 | 44 | 143 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | alpha-hydroxybutyric acid measurement | 1.49e-03 | 12 | 143 | 2 | EFO_0010458 | |
| Disease | alcohol consumption measurement, alcohol drinking | 1.49e-03 | 12 | 143 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | remnant cholesterol measurement | 1.92e-03 | 108 | 143 | 4 | EFO_0010815 | |
| Disease | heart failure | 2.12e-03 | 185 | 143 | 5 | EFO_0003144 | |
| Disease | phospholipids in large LDL measurement | 2.19e-03 | 53 | 143 | 3 | EFO_0022174 | |
| Disease | free cholesterol measurement | 2.26e-03 | 113 | 143 | 4 | EFO_0008591 | |
| Disease | Bipolar Disorder | 2.34e-03 | 477 | 143 | 8 | C0005586 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.35e-03 | 15 | 143 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.35e-03 | 15 | 143 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.35e-03 | 15 | 143 | 2 | C0154091 | |
| Disease | Hypertriglyceridemia | 2.35e-03 | 15 | 143 | 2 | C0020557 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.35e-03 | 15 | 143 | 2 | C0428908 | |
| Disease | eosinophil count | TBXAS1 HECTD4 GCKR NACAD ADGRL4 CELSR1 RUNDC3A TBC1D4 AHR TMEM131 GNAO1 SNRNP200 LDLRAD4 MYO16 NOTCH2 KPNA2 | 2.36e-03 | 1488 | 143 | 16 | EFO_0004842 |
| Disease | Antithrombotic agent use measurement | 2.43e-03 | 55 | 143 | 3 | EFO_0009925 | |
| Disease | Tremor, Rubral | 2.68e-03 | 16 | 143 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.68e-03 | 16 | 143 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.68e-03 | 16 | 143 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 2.68e-03 | 16 | 143 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.68e-03 | 16 | 143 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 2.68e-03 | 16 | 143 | 2 | C0427190 | |
| Disease | phospholipids in LDL measurement | 2.83e-03 | 58 | 143 | 3 | EFO_0022294 | |
| Disease | fibrinogen measurement, factor VII measurement | 2.83e-03 | 58 | 143 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | phospholipids in small LDL measurement | 2.97e-03 | 59 | 143 | 3 | EFO_0022297 | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 3.02e-03 | 17 | 143 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 3.02e-03 | 17 | 143 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | caudal anterior cingulate cortex volume measurement | 3.02e-03 | 17 | 143 | 2 | EFO_0010289 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 3.35e-03 | 126 | 143 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.37e-03 | 206 | 143 | 5 | C0152013 | |
| Disease | Carcinoma of bladder | 3.39e-03 | 18 | 143 | 2 | C0699885 | |
| Disease | cardiomyopathy (is_implicated_in) | 3.78e-03 | 19 | 143 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 3.78e-03 | 19 | 143 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.78e-03 | 19 | 143 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | caffeine metabolite measurement | 3.78e-03 | 19 | 143 | 2 | EFO_0007872 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.04e-03 | 215 | 143 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | Global developmental delay | 4.07e-03 | 133 | 143 | 4 | C0557874 | |
| Disease | venous thromboembolism, fibrinogen measurement | 4.26e-03 | 67 | 143 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 4.45e-03 | 220 | 143 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | DNA methylation | 4.81e-03 | 656 | 143 | 9 | GO_0006306 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEGNINVFSVIPEEF | 1111 | Q13075 | |
| FLAELVFLVGINTNT | 471 | Q9HBW9 | |
| EFLLQALNGFVLVVT | 116 | P35869 | |
| FAQEFINEVGVVTLI | 356 | Q6PI77 | |
| ITDILVTEFGNNFIN | 1641 | O00555 | |
| GTLLQAFVAEVAEQI | 506 | Q8NHU2 | |
| AFVAEVAEQIVGIAV | 511 | Q8NHU2 | |
| IVGIGVDDVFVFINT | 526 | Q9P2K9 | |
| VFIDVIESVNLLVNA | 171 | Q9Y6Q5 | |
| IQVVFRNALEIGFLV | 201 | Q9UKL4 | |
| NIFVALIIITFQEQG | 1416 | Q15878 | |
| GIFVRQSQIQVFEDG | 86 | Q14203 | |
| LQDVFNTVGADIIQL | 11 | O00429 | |
| EEEQVQLVGNIFLEF | 96 | A1IGU5 | |
| FRNIEVVFELGVTFN | 56 | P12104 | |
| VGDRLVFTAIVNNTF | 241 | Q8WYK0 | |
| FIALEIVDEQVQLTF | 1491 | Q9NYQ6 | |
| VEGNIPEVFQLDIFS | 961 | Q9HCU4 | |
| FVALEVIQEQVQLTF | 1416 | Q9HCU4 | |
| AFFQELVIAGIVENE | 201 | P11836 | |
| LVIAANVFAVAAFQV | 136 | O75907 | |
| VVAVTDENIVGLFAA | 196 | Q8IV53 | |
| FVALIIITFQEQGDK | 1411 | Q00975 | |
| QLEAQFEAGLVNVVL | 276 | Q16853 | |
| QIQIESIFNIKGFVD | 241 | Q8N123 | |
| IVDFFAGLNIVDITF | 266 | Q12849 | |
| DTQVNELVLFTVFGF | 191 | Q8NH69 | |
| FVIDRIGDILVQQFS | 926 | Q8N1W1 | |
| DTANIEIVIIFFGNF | 191 | Q8NGQ6 | |
| EIVIIFFGNFVILAN | 196 | Q8NGQ6 | |
| AAVAADAQGVFQILI | 1916 | Q04721 | |
| FSIVFVVIDNLLLGT | 116 | Q8NH92 | |
| EAFSVFGQVERAVVI | 166 | Q15233 | |
| VVGFSSLEVENLFVI | 651 | Q9Y6X6 | |
| EVETFAFQAEIAQLI | 11 | Q58FF7 | |
| AFFVGILVQQIADLI | 936 | P54707 | |
| VLQFENGSIIVVFDL | 111 | P98073 | |
| INDEIFVELVNALGQ | 166 | Q15910 | |
| EEFGFILDNVQSLLI | 1116 | Q9HCM2 | |
| FQASVTVEIFVLDVN | 2991 | Q9NYQ8 | |
| ILFLFGNEEVKVSVN | 136 | Q96DT0 | |
| LVEAVGFLNINPFVE | 176 | Q96DT0 | |
| LLGNAAIFFVIQTEQ | 41 | Q96RD3 | |
| GVFIITTLELANDFQ | 91 | Q5SWX8 | |
| LVAQSQIGFIDFIVE | 416 | Q01064 | |
| VQTFGDILQLVIVEL | 216 | P53618 | |
| SNVFHVVEGFALVIL | 681 | O94915 | |
| ADEVLQSFLQSQVVI | 456 | Q8N8V2 | |
| DVVVNIFINSFGSIQ | 81 | P48167 | |
| EQQSFLVVVAVDFGT | 51 | O43301 | |
| GQVLFVVVDVAADNE | 306 | Q13087 | |
| ELSNGFFIQDQIALV | 76 | Q9BSG0 | |
| DIFELVVENGVFVAN | 46 | Q9Y4D8 | |
| VAVSIGFAVRQELEF | 116 | O14732 | |
| DFLNNLATGLVFIIV | 116 | Q92982 | |
| NIDINIILDVVFVGF | 191 | Q8NH89 | |
| FVAATLLGAVVQVEI | 141 | Q6V1P9 | |
| VVFIFTLDDNLTEVQ | 406 | Q14397 | |
| EQTQVVIDAGALAVF | 326 | P52292 | |
| QFFVEEQSITIVRGL | 2371 | Q5VST9 | |
| LDFIQTLLQVVGVVS | 841 | O15439 | |
| VLSVGADNIFIFVLE | 706 | Q9UHC9 | |
| VENFVTLVVFGLIFA | 31 | P47211 | |
| LLQFVQLLETFVGED | 816 | A4FU69 | |
| LRFGIIDVTEVQIFI | 206 | Q9Y6K0 | |
| VFLFTDTQIVVEEFL | 2501 | Q9C0G6 | |
| STILGNFEEEFLVNV | 531 | Q4G0P3 | |
| SNIQFVFDAVTDVII | 331 | P19086 | |
| FNLLVAILVEGFQAE | 956 | O43497 | |
| FLGVFTVILEQVNVI | 131 | Q13698 | |
| LQVDGVFVTLPFQLD | 2151 | Q9Y6R7 | |
| DEQFAAIIVLGFATL | 1176 | Q53EP0 | |
| IIDFFRNFTVEVVGV | 501 | Q7Z3C6 | |
| NVLDGFLVFVSIIDI | 1241 | Q9P0X4 | |
| FRAGVEEVISVTIFN | 41 | Q8IZJ3 | |
| GIDVEQVSVVINFDL | 396 | Q9UMR2 | |
| DGALEIIATIQVFTQ | 306 | Q00597 | |
| FGVVTAIDLLNFVAA | 531 | P35520 | |
| DFIQELSEVLVQFGI | 391 | Q6ZUT9 | |
| ENVSILFADIVGFTQ | 316 | O60266 | |
| VKEVFELLGVENVFQ | 286 | Q6IQ26 | |
| QEVFETNVFGHFILI | 136 | P56937 | |
| AIISQQGDIFVFDLE | 806 | O00462 | |
| EVEILFIQVNQFALA | 391 | Q9HBU6 | |
| TVVEFIIQVQINFFE | 1141 | Q6ZTR5 | |
| GILTQFEQIVAVFNA | 341 | Q8TC92 | |
| FDLIAVVAGVVQTIL | 176 | P33947 | |
| VSVGIVLIQVFKEFN | 301 | Q7RTP0 | |
| IFVGFVIVTFQEQGE | 1146 | Q01668 | |
| IVNASVEVVNVFFEG | 51 | Q9H596 | |
| IFTLDEVAFIQNLVF | 156 | P46019 | |
| DLLAQEAQFVVTIGN | 301 | Q8N309 | |
| NTQAVELVAFVIAVV | 191 | Q8NGZ6 | |
| QGENVFFVVTNLIVT | 96 | Q93086 | |
| EEFVNFAAILEQILS | 56 | Q59EK9 | |
| NTDGAVNFQEFLILV | 61 | P05109 | |
| QFTLGILVNCFIELV | 16 | Q9NYW6 | |
| GLEAVLQVVAIAAFT | 201 | Q96HE8 | |
| EVQQGNIFIVDFELL | 276 | P09917 | |
| GLVISGFEVIEQIEN | 141 | P30414 | |
| NAELQVTLFGIFLVV | 36 | P0C617 | |
| VLEDEVVIGFAISQQ | 56 | Q8NAU1 | |
| NIQVVFDAVTDIIIA | 331 | P09471 | |
| VRLINIVFDETGHFV | 356 | Q96BP3 | |
| ELFLIFILFQTVQDG | 136 | Q9BVG9 | |
| EEVHVNEVLFIIVFG | 201 | P48764 | |
| NEVLFIIVFGESLLN | 206 | P48764 | |
| VHVNETLFIIVFGES | 196 | Q14940 | |
| LFVEAVEQNTLQEFL | 76 | Q9H299 | |
| QTVEEFVGELNFGLV | 1156 | Q15477 | |
| VFQELNNFNGVLEVV | 861 | Q07889 | |
| SLVVQLLQFQEEVFG | 51 | Q8TAQ2 | |
| IFIFGVLNVQTVEEV | 131 | Q9UKV5 | |
| NFVVQVSVFIGVLID | 416 | O96005 | |
| VSKELVGEFLQFVQL | 11 | Q86XI2 | |
| LFFLGTAVSLQVDIV | 11 | P13591 | |
| FVVLALFAVTQAEEG | 6 | P43308 | |
| LTVDEIVGQAFIFLI | 326 | P24557 | |
| VIVVLLVDTGEQRFF | 391 | Q96KV7 | |
| LVFTEILQNDVQEFI | 646 | P55060 | |
| DIQVNLIVGCIEVVF | 1146 | Q96RL7 | |
| QVAIIAGNFELAEVI | 321 | Q9BYB0 | |
| IIGALVDQAVFEELI | 611 | Q0IIM8 | |
| EVEGVLSQVDFLQQV | 566 | Q9Y2P5 | |
| LFFQLVDVNTGAELT | 416 | P04844 | |
| FTLAQAEDSVFVIVN | 106 | Q8IWA0 | |
| QGFVFDIVTRQAFDI | 1466 | Q9Y5Y9 | |
| VVIAQVLQDLGDFLA | 246 | Q96HA7 | |
| LELLIFFSVVNVSVG | 96 | Q12893 | |
| FDVVFLARVVGNVEN | 171 | Q92545 | |
| VVNNIAVAEQIGELF | 171 | Q6Q0C0 | |
| GINIFFITIEGAAEN | 421 | Q6UXI7 | |
| ITLVNVFIGQAELAE | 86 | O43674 | |
| QFTENLGTILIFAVV | 181 | P19634 | |
| IQGIVFDFVTQQAFD | 1511 | Q9UQD0 | |
| IAFARNQGFDVVLVD | 506 | P08240 | |
| LVEDFLSGFQVVVLT | 151 | P22314 | |
| VARVFDIIFLQGTEV | 1101 | O60343 | |
| LVEQLFSSGAIQVVV | 1631 | O75643 | |
| LVAIVGFQVLNAIEN | 126 | Q9NXH8 | |
| LVDVRVFVSNVFNVD | 61 | Q401N2 | |
| QGIRIEFVGQIELFN | 66 | O75436 | |
| VIEALINEIFLSIGV | 826 | Q7Z7G8 | |
| QGLVFDIVTSQIFDI | 1356 | Q9UI33 | |
| VFQIGERIFLAVANS | 531 | Q8WU66 | |
| QDLVVGNIVKIFDAF | 1521 | Q9Y4F4 | |
| SVGLFVFNLANLEVE | 326 | A2RRH5 | |
| ISELGIQEFFTEQNL | 91 | P51580 | |
| IFVELQGFLAAEQDI | 6 | Q15631 | |
| IAFELVGAQDVSQAI | 406 | Q8TF71 | |
| TIILDQININFVVDA | 241 | P48048 | |
| LLQQDFELVVFLDGT | 286 | P48048 | |
| AGNIFVVSLAVADLV | 61 | P48039 | |
| PGIFNSELEFAQIII | 56 | O15165 | |
| GIFAEEQTLVLQIVA | 266 | Q12965 | |
| LPFQGSLIFQVEAVE | 311 | O15069 |